Using virtual histology intravascular ultrasound no differences in atheroma volume were found between 330 patients with angiographically documented CAD randomized to the selective Lp-PLA2 inhibitor darapladib or to placebo [46]. Here, PLA2G7 is linked to coronary artery disorder.